Bharat Biotech: TB vaccine MTBVAC gets CDSCO nod for phase II trials
The MTBVAC is the first vaccine against Tuberculosis derived from a human source to begin clinical trials
Read full article »
Bharat Biotech is an India-based biotechnology company that researches and develops vaccines and therapeutics for infectious diseases such as diarrhoea and Covid-19.
Read more